搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
ALS News Today
2 天
Vitamin B12 treatment Rozebalamin approved for ALS in Japan
Rozebalamin, an ultra-high dose form of vitamin B12, was approved in Japan to slow disease progression in people with ALS.
ALS News Today
2 天
ALS and the heavy burden of grief
After her late husband's diagnosis anniversary, columnist Juliet Taylor reflects on how grief became a heavy burden and a ...
ALS News Today
3 天
Initiative to use AI technologies to improve communication in ALS
The Scott-Morgan Foundation is launching a joint initiative that aims to use AI technologies to help improve communication ...
ALS News Today
4 天
Texas Children’s investigator wins $2.4M grant for ALS research
A Texas Children’s Hospital investigator won a $2.4 million NIH grant for ALS and other neurodegenerative disease research.
ALS News Today
5 天
RNS60 aids mitochondria health, protects motor neurons in ALS mice
RNS60 is an experimental therapy designed to boost the formation of new mitochondria and restore energy production in nerve ...
ALS News Today
10 个月
Thunder Road — Juliet Taylor
Juliet lost her husband, Jeff, to ALS in 2020, 19 months after his diagnosis. Together Jeff and Juliet enjoyed being on the water, live music, pets, and traveling. She was his primary caregiver, and ...
ALS News Today
6 天
NeuroSense moving to request early approval of PrimeC in Canada
NeuroSense plans to apply to Canada’s regulators for early marketing approval of the oral therapy, supported by a Phase 2b ...
ALS News Today
11 天
Neuvivo requests FDA approval of ALS treatment NP001
Neuvivo has filed an application with the U.S. Food and Drug Administration (FDA) requesting the approval of its ...
ALS News Today
9 天
Avextra to launch Phase 2 trial of cannabis-based medicine in Italy
Avextra plans a Phase 2 trial in Italy to test a cannabis-based oral medicine to ease symptoms in ALS and other ...
ALS News Today
12 天
FGF4 shows benefits in ALS but fails to protect motor neurons
In an ALS study, growth factor FGF4 reduced the activity of star-shaped cells called astrocytes but did not stop motor ...
ALS News Today
3 天
An AI voice can improve quality of life for people with ALS
People with ALS can benefit from voice-generating artificial intelligence, improving their quality of life, columnist Kristin Neva writes.
ALS News Today
13 天
Differences in tears can distinguish bulbar-onset ALS vs. spinal-onset
Differences in human tears in ALS can distinguish bulbar-onset disease from spinal-onset ALS, making this a possible ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈